Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RIGL
RIGL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RIGL News
Rigel Pharmaceuticals Grants Restricted Stock Units to Employees
1d ago
PRnewswire
Rigel Pharmaceuticals Appoints New Chief Medical Officer
Jul 01 2026
NASDAQ.COM
Rigel Pharmaceuticals Announces CMO Transition and Stock Movement
Jul 01 2026
NASDAQ.COM
Rigel Pharmaceuticals Appoints New Chief Medical Officer
Jul 01 2026
seekingalpha
Rigel Pharmaceuticals Appoints New Chief Medical Officer
Jul 01 2026
PRnewswire
Rigel Pharmaceuticals Closes License Agreement for VEPPANU
Jun 16 2026
PRnewswire
Rigel Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 27 2026
PRnewswire
Rigel Pharmaceuticals Presents GAVRETO Phase 3 Data at ASCO 2026
May 21 2026
PRnewswire
Rigel Pharmaceuticals to Present GAVRETO and REZLIDHIA Data at ASCO Annual Meeting
May 21 2026
Newsfilter
Rigel Pharmaceuticals to Present at RBC Capital Markets Global Healthcare Conference
May 14 2026
PRnewswire
Rigel Partners with Arvinas and Pfizer for Breast Cancer Treatment
May 12 2026
stocktwits
Arvinas and Rigel Reach Licensing Agreement for Breast Cancer Therapy
May 12 2026
seekingalpha
Rigel Pharmaceuticals Q1 2026 Earnings Call Insights
May 06 2026
seekingalpha
Rigel Pharmaceuticals Reports Q1 Earnings Decline
May 06 2026
NASDAQ.COM
Rigel Pharmaceuticals Q1 Earnings Miss Expectations
May 05 2026
seekingalpha
Rigel Pharmaceuticals to Report Q1 2026 Financial Results
Apr 28 2026
PRnewswire
Show More News
